<div id="readability-page-1"><div> <div> Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Pomdoctor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Pomdoctor between October 9, 2025 and December 11, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information], /PRNewswire/ -- Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Pomdoctor Limited (&#34;Pomdoctor&#34; or the &#34;Company&#34;) (NASDAQ: POM) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Continue Reading <div> <div> <div> <div> <figure> <img id="imageid_2" src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/> <figcaption> James (Josh) Wilson, Faruqi &amp; Faruqi Senior Partner (PRNewsfoto/Faruqi &amp; Faruqi, LLP) </figcaption> </figure> </div> </div> </div> </div> Faruqi &amp; Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that PomDoctor was the subject of a fraudulent stock promotion scheme involving social media based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; (3) that PomDoctor's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Pomdoctor experienced a significant decline in its share price between December 10 and December 11, 2025. The company's stock closed at approximately $0.50 per share on December 10, 2025, before falling to about $0.38 per share at the close of trading on December 11, 2025, representing a decline of roughly $0.12 per share, or approximately 24%, in a single trading session. The drop followed heightened volatility and selling pressure in the stock, amid broader investor concerns regarding Pomdoctor's financial performance and valuation.The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi &amp; Faruqi, LLP also encourages anyone with information regarding Pomdoctor's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Pomdoctor class action, go to www.faruqilaw.com/POM or call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).Follow us for updates on LinkedIn, on X, or on Facebook.Attorney Advertising. The law firm responsible for this advertisement is Faruqi &amp; Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.SOURCE Faruqi &amp; Faruqi, LLP<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjI3Jk5ld3NJdGVtSWQ9Tlk5Njk0NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMjcwODQ0UFJfTkVXU19VU1BSX19fX19OWTk2OTQ3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjI3Jk5ld3NJdGVtSWQ9Tlk5Njk0NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMjcwODQ0UFJfTkVXU19VU1BSX19fX19OWTk2OTQ3"/></div> </div></div>

Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Limited (NASDAQ: POM) and reminds investors of the April 6, 2026 deadline to seek lead plaintiff status in a federal securities class action. The firm alleges that Pomdoctor and its executives made misleading statements and failed to disclose a fraudulent stock promotion scheme, leading to a significant decline in share price. Investors who suffered losses between October 9, 2025, and December 11, 2025, are encouraged to contact the firm for legal options.

08:44 ETPOM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026